Loading data
CBATNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 195.19 m USD | 176.62 m USD | 204.44 m USD | 248.73 m USD | 52.67 m USD |
| Cost of revenue | 167.26 m USD | 126.88 m USD | 163.02 m USD | 222.57 m USD | 43.98 m USD |
| Gross profit | 27.93 m USD | 49.73 m USD | 41.42 m USD | 26.16 m USD | 8.69 m USD |
| Research and development expense | 15.8 m USD | 13.01 m USD | 11.93 m USD | 10.64 m USD | 5.27 m USD |
| Selling, general and administrative expense | 36.87 m USD | 32.51 m USD | 31.91 m USD | 23.21 m USD | 16.82 m USD |
| Operating profit after depreciation | -18.44 m USD | 9.26 m USD | -182 k USD | -5.12 m USD | -11.71 m USD |
| Operating profit before depreciation | -8.94 m USD | 17.22 m USD | 9.51 m USD | 2.95 m USD | -8.13 m USD |
| EBIT | -18.44 m USD | 9.26 m USD | -182 k USD | -5.12 m USD | -11.71 m USD |
| EBITDA | -8.94 m USD | 17.22 m USD | 9.51 m USD | 2.95 m USD | -8.13 m USD |
| Interest expense | 1.28 m USD | 2.06 m USD | 1.53 m USD | 655 k USD | 485 k USD |
| Profit before tax | -11.14 m USD | 11.14 m USD | -6.05 m USD | -12.56 m USD | 53.83 m USD |
| Income tax expense | -185 k USD | 1.56 m USD | 2.49 m USD | -1.23 m USD | -7.73 m USD |
| Income before extraordinary items | -9.38 m USD | 11.79 m USD | -2.45 m USD | -9.45 m USD | 61.49 m USD |
| Net income (reported basis) | -9.38 m USD | 11.79 m USD | -2.45 m USD | -9.45 m USD | 61.49 m USD |
| Basic EPS including extraordinary items | -0.1 USD/share | 0.13 USD/share | -0.03 USD/share | -0.11 USD/share | 0.7 USD/share |
| Diluted EPS including extraordinary items | -0.1 USD/share | 0.13 USD/share | -0.03 USD/share | -0.11 USD/share | 0.7 USD/share |
| Common dividends | 0 USD | 0 USD | 0 USD | 0 USD | 0 USD |
| Total dividends | 0 USD | 0 USD | 0 USD | 0 USD | 0 USD |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.